CTOs on the Move

Landauer

www.landauer.com

 
Landauer is committed to providing unrivaled radiation monitoring service and to ongoing discovery for improving radiation safety Landauer is the global leader in radiation science and services. We provide tools and support to organizations with potential exposure to ionizing radiation, helping them achieve their radiation safety goals. Our proprietary, state-of-the-art optically stimulated luminescence (OSL) technology enables the most precise measurements possible for occupational radiation monitoring and environmental monitoring and a full range of specialized applications including machine quality assurance and patient radiation monitoring. We back our advanced technology with the most flexible dosimetry programs and best customer service the industry has ...
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

SGE Inc

SGE Inc is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

KYTOGENICS

KYTOGENICS is a Chatham, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VQ OrthoCare

VQ OrthoCare is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Optogenics Of Syracuse Inc

Optogenics Of Syracuse Inc is a Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shockwave Medical

Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotrispy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. In peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, IVL demonstrated safety and consistent procedure success with low procedural complications. The technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatments. And because it is built on a traditional balloon catheter platform, it integrates seamlessly with clinicians` existing workflow.